Legislation related to anti-microbial resistence generally
2025 · 1st Quarter (Jan 1 - Mar 31)
INFECTIOUS DISEASES SOCIETY OF AMERICA
Filed by ARENTFOX SCHIFF LLP.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 19, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- ARENTFOX SCHIFF LLP
- Filing UUID
- a4c56884-be97-445b-8df8-9386738e77c5
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Fiscal Year 2026 funding for Bio-Preparedness Workforce Pilot Program, programs dealing with antimicrobial resistance, and programs dealing with infectious diseases generally H. Con. Res 14, regarding funding for infectious diseases programs generally S. Con. Res 7, regarding funding for infectious diseases programs generally H.R. 1968 (Full-Year Continuing Appropriations and Extensions Act, 2025), regarding funding for Infectious diseases programs FY 2025 funding for infectious diseases programs generally Note: Elizabeth Horner, a lobbyist for the listed client, did not lobby, and did not make any communication to, appearance before, or lobbying contact with, the Senate, any Senator or any officer or employee of the Senate, on behalf of the listed client.
Literal federal measure citations: H. Con. Res 14, S. Con. Res 7, H.R. 1968
Medicare reimbursement regarding evaluation and management services by infectious disease physicians, including 2026 Physician Fee Schedule
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.